Again,
maybe a little out there but I believe my question is valid and relevant.
As NNZ2566 reduces or limits the number and / or severity of post TBI convulsive and non convulsive seizures, which accounts for loss of healthy brain tissue post TBI, is it not conceivable that there may even be an application for the treatment of epilepsy or certain forms of epilepsy which also is a huge market.
I have no medical training and if I'm off the mark or missing something let me know.
Just thought I'd put it out there and see what people think?
rett syndrome reversal, page-11
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.13 |
Change
0.020(0.15%) |
Mkt cap ! $1.678B | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.44 | $13.07 | $5.021M | 378.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 11501 | $13.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.18 | 1539 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |